BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18295925)

  • 21. Role of health technology assessment in shaping the benefits package in The Netherlands.
    Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health technology assessment in Switzerland.
    Koch P; Schilling J; Läubli M; Mitscherlich F; Melchart D; Bellucci S
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():174-7. PubMed ID: 19534839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linking evidence from health technology assessments to policy and decision making: the Alberta model.
    Borowski HZ; Brehaut J; Hailey D
    Int J Technol Assess Health Care; 2007; 23(2):155-61. PubMed ID: 17493300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOW CAN HEALTH SYSTEMS PREPARE FOR NEW AND EMERGING HEALTH TECHNOLOGIES? THE ROLE OF HORIZON SCANNING REVISITED.
    Oortwijn W; Sampietro-Colom L; Habens F; Trowman R
    Int J Technol Assess Health Care; 2018 Jan; 34(3):254-259. PubMed ID: 29888687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".
    Henshall C; Schuller T; Mardhani-Bayne L
    Int J Technol Assess Health Care; 2012 Jul; 28(3):203-10. PubMed ID: 22792877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health services research in Europe and its use for informing policy.
    Ettelt S; Mays N
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():48-60. PubMed ID: 21737529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonography.
    Husereau D; Morrison A; Battista R; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):343-52. PubMed ID: 19394575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology.
    Fattore G; Maniadakis N; Mantovani LG; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii49-53. PubMed ID: 21518750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public health policy decisions on medical innovations: what role can early economic evaluation play?
    Hartz S; John J
    Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decade to the Israeli Center for Technology Assessment in Health Care.
    Tamir O; Shemer J; Shani M; Vaknin S; Siebzehner MI
    Isr Med Assoc J; 2008 Dec; 10(12):901-5. PubMed ID: 19160954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early awareness and alert activities in Latin America: current situation in four countries.
    Pichon-Riviere A; Silva Elias FT; Rivero VG; Vaca CP
    Int J Technol Assess Health Care; 2012 Jul; 28(3):315-20. PubMed ID: 22980710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EUROSCAN INTERNATIONAL NETWORK MEMBER AGENCIES: THEIR STRUCTURE, PROCESSES, AND OUTPUTS.
    Packer C; Simpson S; de Almeida RT
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):78-85. PubMed ID: 26077793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is there agreement on the determination of public health priorities in Europe?].
    Duriez M; Lequet-Slama D; Chambaud L
    Sante Publique; 2000 Dec; 12(4):485-96. PubMed ID: 11349333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary survey on the influence of rapid health technology assessments.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health technology assessment agencies: an international overview of organizational aspects.
    Martelli F; La Torre G; Di Ghionno E; Staniscia T; Neroni M; Cicchetti A; Von Bremen K; Ricciardi W;
    Int J Technol Assess Health Care; 2007; 23(4):414-24. PubMed ID: 17937828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.